Glenmark's revenues up 23%, led by Indian and US growth
This article was originally published in Scrip
Executive Summary
Glenmark Pharmaceuticals has reported a robust 23% increase in revenues to Rs7.24 billion ($155.2 million) for the second quarter ended 30 September, backed by growth in the Indian and US businesses. Net profit rose by 38% to Rs1.12 billion.